High‐quality evidence lacking for cannabinoids in medical treatment

A review and meta‐analysis of studies of cannabinoids for a variety of medical conditions has found that while symptom improvement was common in the studies, it was less likely to see a statistically significant impact of cannabinoid treatment. The highest‐quality evidence seen in the 79 analyzed trials was for use of cannabinoids in the treatment of chronic pain and spasticity. The vast majority of the trials examined cannabinoid drugs and not smoked marijuana, leading the researchers to conclude that more studies of cannabis itself should be conducted. Results of the review and meta‐analysis were published in the June 23–30, 2015, issue of the Journal of the American Medical Association.
Source: The Brown University Psychopharmacology Update - Category: Psychiatry Tags: Medical Treatment Source Type: research